BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Sep 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-09-13

Reporting Person: Davis George Eric (EVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-13	Common Stock	S	12000	$99.57	Disposed	74950	Direct

Footnotes

F1: The reporting person contributed shares of common stock of BioMarin Pharmaceutical Inc. (the "Common Stock") to an exchange fund in exchange for shares of the exchange fund. The Common Stock was valued at $99.57 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.